USC-Brookings Schaeffer Initiative for Health Policy
Our work in USC-Brookings Schaeffer Initiative for Health Policy
-
How the Cares Act Affects COVID-19 Test Pricing
How will the CARES Act impact COVID-19 test pricing? One of our Schaeffer Initiative experts suggests a change to require insurers to pay for testing at Medicare prices and prohibit balance billing patients.
-
States Will Need More Fiscal Relief. Policymakers Should Make That Happen Automatically.
Without assistance from the federal government, states will likely be forced to make deep program cuts, enact substantial tax increases, or both. Either strategy would worsen the economic downturn and its aftermath.
-
Misleading Marketing of Short-Term Health Plans Amid COVID-19
Schaeffer Initiative researchers investigate marketing claims made by ACA non-compliant health insurers about coverage amid the pandemic.
-
How Would Sharing Rebates at the Point-Of-Sale Affect Beneficiary Cost-Sharing in Medicare Part D?
If cost-sharing were based on net price it would provide meaningful financial relief to many Part D beneficiaries.
-
WEBINAR: 24th Annual Wall Street Comes to Washington Health Care Roundtable
Paul Ginsburg will discuss what the latest market developments mean for national health policy and how federal policies may affect the outlook for healthcare companies with Wall Street analysts.
Categorized in -
Comments Submitted on HHS Notice of Benefit and Payment Parameters for 2021
Schaeffer Initiative fellows provided comments to HHS on a proposed rule regarding the provision of advance premium tax credits for individuals receiving financial assistance under the ACA.
-
The ACA’s Individual Mandate In Retrospect: What Did It Do, And Where Do We Go From Here?
A USC-Brookings Schaeffer Initiative expert examines if the mandate meaningfully increased coverage and what can be learned from the ACA if policymakers want to achieve universal coverage in the future.
-
Health Care in President Trump’s Fiscal Year 2021 Budget
Our Schaeffer Initiative experts evaluate the president’s budget in a piece in JAMA Health Forum. The budget includes Medicare provider and drug payment reforms, as well as some policies that will impact the Affordable Care Act.
-
Georgia’s 1332 Waiver Violates the ACA and Cannot Lawfully be Approved
Christen Linke Young and Jason Levitis explain why Georgia’s 1332 waiver would fail the affordability guardrail and is based on several assumptions.
-
Remanding Texas v. U.S. to the Lower Court Prolongs Harms to Consumers and the Health Care Industry
How will remanding Texas v. U.S. case to the lower court will affect the health care market? Drug manufacturers face tremendous scientific uncertainty while ACA funding has clearly become a major component in state spending.